Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Sarcoma
•
Medical Oncology
How do you approach patients with lymph node positive osteosarcoma of the extremities for neoadjuvant chemotherapy?
Related Questions
How do you approach patients with SDH deficient advanced GIST tumor for systemic treatment?
Do you ever extend adjuvant imatinib for patients with high-risk, localized GIST beyond 3 years?
How do you approach patients with osteosarcoma of the maxilla for neoadjuvant chemotherapy?
When would you ever consider lifelong imatinib in adjuvant therapy for GIST?
How do you sequence treatment for a patient following R2 resection of a large extremity leiomyosarcoma who has small lung nodules concerning for metastatic disease, but not yet biopsy proven?
How do you approach a young patient with undifferentiated pleomorphic sarcoma of the upper extremity who developed ifosfamide-induced nephrotoxicity after two cycles of adjuvant AIM chemotherapy?
How would you treat a patient with a locally recurrent myxofibrosarcoma, FNCLCC grade 2, that has recurred after multiple resections and radiotherapy?
How would you approach patients with primary cardiac sarcomas for adjuvant systemic treatment?
What systemic treatment do you utilize for patients with metastatic fibrosarcomatous DFSP that have progressed on imatinib?
How do you approach a patient with undifferentiated pleomorphic sarcoma encasing the spinal cord post radiation for neurological deficits for further management?
